Cytek Biosciences Debuts Optimized Immunoprofiling Kit
15 déc. 2020 10h00 HE
|
Cytek Biosciences
FREMONT, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- It just became easier, faster and more efficient to profile the human immune system. Cytek Biosciences Inc., a leading provider of cell analysis...
Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
20 nov. 2020 21h54 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Completes Acquisition of InstruNor AS
26 févr. 2020 08h30 HE
|
Fluidigm Corporation
Acquisition to expand Fluidigm’s industry-leading mass cytometry capabilities and address flow cytometry markets with the addition of fully automated sample prep SOUTH SAN FRANCISCO, Calif., Feb. ...
Fluidigm Receives Life Science Industry Award for the Maxpar Direct Immune Profiling System
09 déc. 2019 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2019 (GLOBE NEWSWIRE) -- BioInformatics Inc., the leading research and advisory firm serving the life science tools market, recognized Fluidigm...
Fluidigm Drives a New Standard in Human Immune Profiling
05 nov. 2019 16h02 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced it has exceeded $1 million in revenue from its industry-leading Maxpar® Direct™...
Fluidigm Becomes the First Company to Enable 50-Plex Cytometry Panels with the Release of Seven New Metal Antibody Labels
24 sept. 2019 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Announces 8th Annual Mass Cytometry Summit
30 avr. 2019 09h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Cofactor Genomics Launches ImmunoPrism™ Immune Profiling Kit, for Use in Clinical Sequencing Laboratories
30 oct. 2018 08h00 HE
|
Cofactor Genomics
--Enables in-house, RNA-based, solid tumor profiling with powerful, cloud-based informatics tools to inform critical clinical decisions-- SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cofactor...
Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrismTM
02 oct. 2018 08h00 HE
|
Cofactor Genomics
CAP/CLIA validation of ImmunoPrismTM furthers Cofactor’s mission of leveraging RNA to build unique, transformative assays informing critical clinical decisions SAN FRANCISCO, Oct. 02, 2018 (GLOBE...
Cofactor Genomics announces new collaboration with the National Cancer Institute (NCI) to demonstrate power of RNA-based immune profiling assay
20 mars 2018 08h30 HE
|
Cofactor Genomics
SAN FRANCISCO, March 20, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, leading developer of advanced RNA analysis tools, announced today that they have entered into an agreement with the National...